# The Efficacy of Sodium Butyrate and Probiotics in Patients With Irritable Bowel Syndrome

> **NCT05013060** · NA · COMPLETED · sponsor: **Nordic Biotic Sp. z o.o.** · enrollment: 120 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotics and microcapsulated sodium butyrate
- **DIETARY_SUPPLEMENT:** Maltodextrin

## Key facts

- **NCT ID:** NCT05013060
- **Lead sponsor:** Nordic Biotic Sp. z o.o.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-15
- **Primary completion:** 2023-09-30
- **Final completion:** 2024-01-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05013060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05013060, "The Efficacy of Sodium Butyrate and Probiotics in Patients With Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05013060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*